PICCOLETO-XIImpact of Aggressive vs Standard Lesion Preparation on Drug-coated Balloon Angioplasty for In-stent Restenosis
This observational study aims to compare the impact of aggressive versus standard lesion preparation on drug-coated balloon angioplasty for in-stent restenosis, specifically focusing on the occurrence of major adverse cardiovascular events such as cardiac death, non-fatal myocardial infarction, or target lesion revascularization.
Data Collection
Collected from past medical records and data - RetrospectiveArterial Occlusive Diseases+5
+ Arteriosclerosis
+ Cardiovascular Diseases
Cohort
Tracking disease incidence in order to identify risk factors and understand disease progression over time.Summary
Study start date: June 1, 2026
Actual date on which the first participant was enrolled.The PICCOLETO XI A-PREP study focuses on understanding the impact of different lesion preparation strategies used before drug-coated balloon (DCB) angioplasty for in-stent restenosis (ISR). In-stent restenosis is a condition where a previously placed stent narrows again, posing a significant challenge. The DCB angioplasty is a treatment method that doesn't involve adding more metal layers, which could be beneficial. The study emphasizes the importance of proper lesion preparation for better drug delivery and reduced risk of restenosis. It involves patients who will be grouped based on their lesion preparation strategy, either aggressive or standard. The aggressive approach uses tools like cutting, scoring, or specific types of balloons, while the standard approach uses semi-compliant or non-compliant balloons. The study aims to improve care for those with in-stent restenosis by finding the best preparation method. During the study, participants will undergo their assigned preparation strategy and subsequent DCB angioplasty. The results will be measured based on Major Adverse Cardiovascular Events (MACE), which is a combination of three potential outcomes: cardiac death, non-fatal heart attack, or the need for another procedure on the same treated area. These outcomes will be assessed at one year and the longest available follow-up period. The study's findings could provide insights into the most effective and safe preparation strategies for in-stent restenosis treatment.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.500 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Cohort
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Study Objectives
Primary Objectives
Secondary Objectives